Caplin Point Laboratories (BOM:524742) 3-Year Book Growth Rate : 27.60% (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories 3-Year Book Growth Rate?

Caplin Point Laboratories's Book Value per Share for the quarter that ended in Mar. 2024 was ₹304.93.

During the past 12 months, Caplin Point Laboratories's average Book Value per Share Growth Rate was 23.10% per year. During the past 3 years, the average Book Value per Share Growth Rate was 27.60% per year. During the past 5 years, the average Book Value per Share Growth Rate was 30.60% per year. During the past 10 years, the average Book Value per Share Growth Rate was 45.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Caplin Point Laboratories was 67.00% per year. The lowest was 10.40% per year. And the median was 37.95% per year.

Competitive Comparison of Caplin Point Laboratories's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Caplin Point Laboratories's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's 3-Year Book Growth Rate falls into.

Caplin Point Laboratories 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Caplin Point Laboratories (BOM:524742) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Caplin Point Laboratories 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Caplin Point Laboratories (BOM:524742) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

CAPLIPOINT:India

Address

Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096

Website

https://www.caplinpoint.net

Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories (BOM:524742) Headlines

No Headlines